Infection

Buccal Tablets for Oropharyngeal Candidiasis Cleared

Jody A. Charnow May 21, 2010

The FDA has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis in adults and childen aged 16 years and older.
 

Kidney Cancer Linked to Hepatitis C Virus

Jody A. Charnow May 11, 2010

Chronic infection with hepatitis C virus (HCV) increases a person's risk for renal cell carcinoma (RCC), a study found.
 

Donor Race May Affect Survival of HCV-Infected Renal Transplant Patients

Jody A. Charnow May 04, 2010

SAN DIEGO—Non-black renal transplant patients infected with the hepatitis C virus (HCV) have better survival if they receive a kidney from a non-black rather than a black donor, data show.
 

Low-Dose Fluconazole Prophylaxis After Renal Transplantation is Safe and Effective

Jody A. Charnow May 03, 2010

SAN DIEGO—Low-dose fluconazole is safe and highly effective for antifungal prophylaxis after kidney transplantation, according to a study conducted by researchers at University of Utah Health Care in Salt Lake City.
 

Acute Kidney Injury Boosts Mortality In Pneumonia Patients

Delicia Honen Yard April 26, 2010

Acute kidney injury (AKI) increases the risk of death for people hospitalized for even mild-to-moderate community-acquired pneumonia.
 

HCV-Infected Kidneys May Help HCV-Infected Recipients

Delicia Honen Yard April 09, 2010

Although kidneys infected with hepatitis C virus (HCV) were 2.6 times more likely than HCV-free donor kidneys to be discarded than used for transplantation, HCV-positive patients may well derive some benefit from receiving these organs, according to a report in the American Journal of Transplantation (online ahead of print).
 

Post-Transplant Fungal Infections Remain Problematic

Jody A. Charnow March 30, 2010

Fungal infections, especially invasive candidiasis and invasive aspergillosis, remain problematic among solid organ transplant recipients (SOT), but overall mortality appears to have improved, new findings confirm.
 

Pneumococcal Vaccine with Broader Protection Cleared

Jody A. Charnow March 30, 2010

The FDA has approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and children aged six weeks through five years.
 

Post-Op Infectious Complications Characterized

Jody A. Charnow March 02, 2010

The problems developed following 20% of major urologic procedures in patients with chronic bacteriuria.
 

Drug-Resistant Pathogens Threaten ESRD Patients

Jody A. Charnow February 05, 2010

According to researchers, they are responsible for a growing proportion of bloodstream infections in dialysis and renal transplant patients.
 

Rituximab May Increase Infection Risk in Kidney Transplant Patients

Jody A. Charnow January 08, 2010

Use of rituximab in kidney transplant patients is associated with a high risk of infections, according to a French study. In addition, rituximab used in combination with antithymocyte globulin is associated with an increased risk of infection-related death.
 

Post-Op Infectious Complications Characterized

Jody A. Charnow January 05, 2010

The problems developed following 20% of major urologic procedures in patients with chronic bacteriuria.
 

Flu Vaccine Advised for Transplant Patients

John Schieszer November 19, 2009

Influenza should be prevented in renal transplant recipients because it can cause allograft rejection.
 

Aggressive Prostate Cancer Linked to Bacteria

John Schieszer November 19, 2009

Trichomonas vaginalis infection associated with a twofold increased risk of advanced prostate cancer
 

Antibiotic UTI Prophylaxis Slightly Better

John Schieszer November 19, 2009

It is associated with fewer recurrences than lactobacilli, but it increases antibiotic resistance.
 

Bacteria Interference May Prevent Urinary Tract Infections

John Schieszer November 19, 2009

A non-pathogenic strain of E. coli lowered the UTI rate in catheterized men with neurogenic bladder.
 

Anti-CMV Drug Cleared for Pediatric Transplant Patients

Jody A. Charnow October 16, 2009

The FDA has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant recipients (aged four months to 16 years) who are at high risk of developing the disease. FDA also approved a new pediatric oral solution formulation for the drug that will enable easier administration to these patients.
 

Vancomycin-Related Renal Toxicity in Children

John Schieszer October 02, 2009

Pediatric patients who attain higher trough levels of the drug may be at higher risk of kdiney damage.
 

Flu Vaccine Advised for Transplant Patients

John Schieszer September 21, 2009

Influenza should be prevented in renal transplant recipients because it can cause allograft rejection.
 

Aggressive Prostate Cancer Linked to Bacterial Infection

John Schieszer September 15, 2009

Trichomonas vaginalis infection is associated with a twofold increased risk of advanced prostate cancer.
 

Circumcision May Help Stop HIV Spread

John Schieszer August 19, 2009

Protection may stem from a decrease in the number of HIV target cells following the procedure.
 

First UTIs in Women Characterized

Jody A. Charnow August 19, 2009

CHICAGO—Urinary frequency and urgency are the two predominant presenting urinary symptoms in young women with their first UTI, according to a new prospective study of college-aged women.
 

FDA: Penile Implant Reduces Infection Risk

Jody A. Charnow August 19, 2009

American Medical Systems' AMS 700 with InhibiZone—a proprietary combination of antibiotics—has received FDA's okay to be marketed as the only inflatable penile prosthesis with clinical evidence showing a significant decrease in the need for revision surgery because of infection.
 

Preemptive CMV Therapy Inferior

Jody A. Charnow July 26, 2009

Continuous prophylaxis (CP) against cytomegalovirus (CMV) is a better strategy than preemptive therapy (PT) for pancreas-kidney transplant (PKT) recipients who are CMV-seropositive, data suggest.
 

Longer CMV Prophylaxis More Effective

Jody A. Charnow June 25, 2009

BOSTON—Longer duration of oral valganciclovir prophylaxis against cytomegalovirus (CMV) in high-risk renal transplant patients significantly reduces the incidence of CMV infection one year post transplant, new findings suggest.
 

Longer CMV Prophylaxis More Effective

Jody A. Charnow June 05, 2009

Longer duration of oral valganciclovir prophylaxis against cytomegalovirus (CMV) in high-risk renal transplant patients significantly reduces the incidence of CMV disease one year post-transplant, new findings suggest.
 

Fatal Infections Probed in Pediatric LN Patients

Jody A. Charnow May 07, 2009

Prior history of treatment with pulse methylprednisolone may increase the risk of fatal infection in pediatric lupus nephritis (LN) patients treated with IV cyclophosphamide (IVCY), researchers reported.
 

Race Affects Bacteremia Rate

Jody A. Charnow May 04, 2009

NASHVILLE—Hispanic hemodialysis (HD) patients have a significantly higher incidence of catheter-related bacteremia compared with African-American HD patients, data show.
 

COPD Peritonitis Linked to Hypokalemia

Jody A. Charnow April 21, 2009

Hypokalemia in patients on continuous ambulatory peritoneal dialysis (CAPD) may be a risk factor for peritonitis and poor nutritional status, data show.
 

Food Safety Issues for CKD Patients

Debra Blair, MPH, RD, CSR March 01, 2009

Foodborne illness affects 76 million people annually in the U.S., resulting in approximately 5,000 deaths, according to estimates by the Department of Health and Human Services and the CDC.
 

Latest News

Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Dialysis Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions